Heart Failure

Roy Gardner graduated from Dundee University in 1996. He is a specialist registrar in cardiology in Glasgow and has a specialist interest in heart failure. He was awarded an MD in 2006 for markers of prognosis in advanced heart failure and has a particular interest in the assessment of patients for cardiac transplantation. Theresa McDonagh graduated from Edinburgh University in 1987. She trained in Cardiology at the Western Infirmary, Glasgow. She was involved in the research into epidemiology of Left Ventricular Dysfunction in North Glasgow and early work on BNP as a biomarker in Heart Failure. Subsequently, she was appointed as a Senior Lecturer to run the Heart Failure Service for Glasgow Royal Infirmary and the Transplant Assessment Programme for Scotland. She has continued research into prognostic biomarkers in Heart Failure. Currently, she is the Clinical and Research lead for Heart Failure at the Royal Brompton Hospital, London, where she combines a clinical interest Heart Failure with clinical research. Niki Walker graduated from Glasgow University in 1993, 1996 and again in 2004. During the course of her PhD she studied ventricular arrythmia mechanisms in heart failure. She is currently a specialist registrar in Cardiology in the West of Scotland deanery.

FOREWORD ; SECTION 1 - CHRONIC HEART FAILURE ; 1. Definition, epidemiology and pathophysiology ; 2. Diagnosis and investigation ; 3. Estimating prognosis ; 4. Non-pharmacological management ; 5. Pharmacological management ; 6. Device therapy ; 7. Revascularisation ; 8. Other surgical techniques ; 9. Cardiac transplantation ; SECTION 2 - CHRONIC HEART FAILURE AND CO-MORBID CONDITIONS ; 10. The patient with heart failure and angina ; 11. The patient with heart failure and arrhythmias ; 12. The patient with heart failure and arthritis ; 13. The patient with heart failure and anaemia ; 14. The patient with heart failure and adult congenital heart disease ; 15. The patient with heart failure and diabetes ; 16. The patient with heart failure and obstructive lung disease ; 17. The patient with heart failure and renal dysfunction ; 18. The patient with heart failure and valvular disease ; 19. The patient with heart failure and specific heart muscle disease ; 20. The patient with heart failure and preserved systolic function ; 21. The patient with heart failure and sleep-disordered breathing ; 22. The patient with heart failure and cancer ; SECTION 3 - ACUTE HEART FAILURE ; 23. Acute Heart Failure - from definition to diagnosis ; 24. Acute Heart Failure - management ; SECTION 4 - PROCEDURES ; 25. Central venous cannulation ; 26. Cardiac catheterisation ; 27. Cardiac biopsy ; 28. IABP insertion ; 29. Cardio-pulmonary exercise testing ; 30. The assessment of dysynchrony ; SECTION 5 - DETAILED PHARMACOLOGY AND EVIDENCE-BASE FOR DRUGS ; 31. ACE inhibitors ; 32. Beta-adrenoreceptor antagonists ; 33. Aldosterone antagonists ; 34. Angiotensin receptor antagonists ; 35. Diuretics ; 36. Inotropes and Vasopressors ; 37. Vasodilators ; SECTION 6 ; 38. How to set up and run a heart failure clinic ; SECTION 7 ; 39. End of life issues